Back
Greystone Housing Impact Investors LP Vs. Sarepta Therapeutics Industry Stock Comparison
Buy
59
GHI
Greystone Housing Impact Investors LP
Last Price:
$12.07
Seasonality Move:
-0.96%
Buy
68
SRPT
Sarepta Therapeutics
Last Price:
$63.37
Seasonality Move:
16.21%
Buy
59
Greystone Housing Impact Investors LP (GHI)
is a Buy
Is Greystone Housing Impact Investors LP a Buy, Sell or Hold?
-
The current Greystone Housing Impact Investors LP [GHI] share price is $12.15. The Score for GHI is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
-
GHI is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
68
Sarepta Therapeutics (SRPT)
is a Buy
Is Sarepta Therapeutics a Buy, Sell or Hold?
-
The current Sarepta Therapeutics [SRPT] share price is $62.78. The Score for SRPT is 68, which is 36% above its historic median score of 50, and infers lower risk than normal.
-
SRPT is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
GHI Stock Price Chart
What is Greystone Housing Impact Investors LP's stock price today?
-
The Greystone Housing Impact Investors LP share price today is $12.15Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and GHI is experiencing selling pressure, which indicates risk of future bearish movement.
SRPT Stock Price Chart
What is Sarepta Therapeutics's stock price today?
-
The Sarepta Therapeutics share price today is $62.78The current trend is relatively stagnant and SRPT is experiencing slight buying pressure.
GHI Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.04 | Sell |
Relative Strength Index (14 RSI): | 54.63 | Buy |
Chaikin Money Flow: | -34283 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (11.18 - 12.24) | Buy |
Bollinger Bands (100): | (11.09 - 12.65) | Buy |
SRPT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -3.59 | Sell |
Relative Strength Index (14 RSI): | 47.63 | Sell |
Chaikin Money Flow: | 403822 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (52.88 - 64.14) | Buy |
Bollinger Bands (100): | (72.05 - 124.85) | Sell |
GHI Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 11.83 | Buy |
20-day SMA: | 11.54 | Buy |
50-day SMA: | 12.2 | Sell |
200-day SMA: | 12.63 | Sell |
8-day EMA: | 11.91 | Buy |
20-day EMA: | 11.81 | Buy |
50-day EMA: | 11.98 | Buy |
200-day EMA: | 12.75 | Sell |
SRPT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 61.07 | Buy |
20-day SMA: | 56.61 | Buy |
50-day SMA: | 77.11 | Sell |
200-day SMA: | 114.34 | Sell |
8-day EMA: | 60.68 | Buy |
20-day EMA: | 61.43 | Buy |
50-day EMA: | 74.36 | Sell |
200-day EMA: | 104.12 | Sell |
Greystone Housing Impact Investors LP Earnings Growth & GHI Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.04 per share, an increase this year of $0.04 per share, and an increase next year of $0.41 per share.
Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates
-
Analysts estimate an earnings increase this quarter of $2.28 per share, a decrease next quarter of $0.51 per share, an increase this year of $3.58 per share, and an increase next year of $6.23 per share.
Greystone Housing Impact Investors LP Technical Analysis
Apr 17 | Apr 21 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 28 | Apr 29 | Apr 30 | May 1 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | ||||||||||
17 | 21 | 22 | 23 | 24 | 25 | 28 | 29 | 30 | 01 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Sarepta Therapeutics Technical Analysis
Apr 17 | Apr 21 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 28 | Apr 29 | Apr 30 | May 1 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | ||||||||||
17 | 21 | 22 | 23 | 24 | 25 | 28 | 29 | 30 | 01 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |